Ardent Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Seven Ardent Health Facilities Earn 2024 Leapfrog Top Hospital Award for Outstanding Quality and Safety
Ardent Health Partners, LLC (NYSE: ARDT) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $20.00 price target on the stock.
Nine Ardent Health Facilities Earn “A” Hospital Safety Grade From The Leapfrog Group
Ardent Health Partners, LLC (NYSE: ARDT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.